Brief: Lensar Receives U.S. FDA Clearance Of Ally Adaptive Cataract Treatment System
13/06/2022 12:21
June 13 (Reuters) - LENSAR Inc LNSR.O :
* LENSAR® RECEIVES U.S. FDA CLEARANCE OF ALLY™ ADAPTIVE
CATARACT
TREATMENT SYSTEM
* LENSAR INC - COMPANY PLANS TO MAKE ALLY WIDELY AVAILABLE
TO
CATARACT SURGEONS IN 2023.
Source text for Eikon: ID:nBw6lwRCLa
Further company coverage: LNSR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LENSAR
See all newsU.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
Lensar Inc Reports Results For The Quarter Ended June 30: Earnings Summary
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies